Natera, Inc. (NTRA)

Services-Medical Laboratories

Latest Price

$413.31

TTM P/E

Normalized P/E

Div Yield

Book Value

12.72

P/B Ratio

32.50

Valuation metrics

Base FCF: $89M (median of recent 5yr)

Growth: 25%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$52.78

87% downside

96.0% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
JPMorgan Chase & Co	12.87M	$3.50B	8.96%	+11.0K	2026-06-30
BlackRock, Inc.	10.91M	$2.96B	7.60%	+237.3K	2026-06-30
Price T Rowe Associates Inc	9.02M	$2.45B	6.28%	-3.16M	2026-06-30
Vanguard Capital Management LLC	6.23M	$1.69B	4.34%	+219.7K	2026-06-30
Vanguard Portfolio Management LLC	5.78M	$1.57B	4.03%	+137.9K	2026-06-30
FMR LLC	5.45M	$1.48B	3.80%	+2.90M	2026-06-30
Wellington Management Group LLP	4.04M	$1.10B	2.81%	-727.9K	2026-06-30
State Street Corp	3.66M	$992.0M	2.55%	+238.1K	2026-06-30
Duquesne Family Office LLC	3.19M	$864.0M	2.22%	+122.7K	2026-06-30
Geode Capital Management, LLC	2.75M	$744.0M	1.91%	-25.9K	2026-06-30